Dpep, a Cell-Penetrating Peptide Targeting ATF5, CEBPB and CEBPD, Synergistically Combines with ABT-263 and Decitabine to Inhibit Cancer Cell Growth and Overcome Dpep Resistance.

Cells · 2026 · PMC13162579 · PMID 42121927

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a trend towards significanceno p-value reported

For 5/6 lines assessed, at least one triple combination showed significant synergy, with the 6th line (MOLM-14 cells) showing a trend towards significance ( Figure 5 F).

also in 2,760 other papers

showed a trendno p-value reported

This combination also showed a trend towards synergy in MOLM-14 cells ( Figure 3 B).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.